Get 20% lifetime commission for referring investors to digrin.com
here.
NervGen Pharma Corp. Common stock ( NGEN) - Key Metrics
NGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.32 | -$0.06 | -$0.06 |
| 2026Q1 | $0 | -$0.02 | -$0.10 | -$0.10 |
| 2025Q4 | $0 | -$0.44 | -$0.14 | -$0.14 |
| 2025Q3 | $0 | -$0.06 | -$0.07 | -$0.07 |
| 2025Q2 | $0 | -$0.13 | -$0.05 | -$0.05 |
NGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.22 |
| 2026Q1 | 0% | -61.57 |
| 2025Q4 | 0% | -4.37 |
| 2025Q3 | 0% | -26.11 |
| 2025Q2 | 0% | -11.17 |
NGEN
Price: $1.59
52 week price:
Earnings Per Share: -0.61 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 152.1 million